Haixia Zhou Selected Research

Heterogeneous-Nuclear Ribonucleoprotein D

1/2020	Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34+ cells via pre-B-cell leukemia homeobox 1.
9/2018	Oncogenic heterogeneous nuclear ribonucleoprotein D-like promotes the growth of human colon cancer SW620 cells via its regulation of cell-cycle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haixia Zhou Research Topics

Disease

16	Neoplasms (Cancer) 12/2021 - 10/2013
12	Infections 12/2021 - 09/2005
7	Neuroblastoma 01/2021 - 01/2018
5	Carcinogenesis 12/2021 - 01/2018
5	Wilms Tumor (Wilm's Tumor) 01/2021 - 12/2019
4	Leukemia 12/2016 - 10/2013
3	Human Influenza (Influenza) 01/2022 - 02/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2015
2	COVID-19 01/2021 - 12/2020
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 11/2015
2	Lung Diseases (Lung Disease) 01/2016 - 11/2009
2	Philadelphia Chromosome 11/2015 - 02/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2015 - 02/2014
2	Coronavirus Infections 10/2010 - 09/2005
2	Severe Acute Respiratory Syndrome 11/2009 - 09/2005
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Neutropenia 12/2021
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Acute Promyelocytic Leukemia 12/2021
1	Pleural Effusion (Pleural Effusions) 02/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Obesity 12/2020
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Glioma (Gliomas) 01/2020
1	Mycoses (Diseases, Fungus) 01/2020
1	Necrosis 01/2020
1	Invasive Fungal Infections 01/2020
1	Lymphatic Metastasis 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Colonic Neoplasms (Colon Cancer) 09/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018
1	Hemorrhage 01/2018
1	Xeroderma Pigmentosum (Kaposi's Disease) 08/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2016
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2016
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2016
1	Liver Diseases (Liver Disease) 01/2016

Drug/Important Bio-Agent (IBA)

9	ORALIT (ORS)IBA 01/2021 - 01/2018
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2005
5	VaccinesIBA 01/2022 - 01/2019
4	N-methyladenosineIBA 12/2021 - 06/2020
3	MethyltransferasesIBA 12/2021 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	Matrix-MIBA 12/2021 - 01/2021
2	NVX-CoV2373 adjuvated lipid nanoparticleIBA 01/2021 - 12/2020
2	Biological ProductsIBA 01/2021 - 01/2020
2	ran-binding protein 2IBA 01/2020 - 01/2018
2	Heterogeneous-Nuclear Ribonucleoprotein DIBA 01/2020 - 09/2018
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 11/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 10/2013
2	Long Noncoding RNAIBA 01/2019 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 04/2010 - 01/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Lysine AcetyltransferasesIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 12/2021
1	Arsenic Trioxide (Trisenox)FDA Link 12/2021
1	AnthracyclinesIBA 12/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021
1	AntigensIBA 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 12/2020
1	HDL LipoproteinsIBA 12/2020
1	NanovaccinesIBA 02/2020
1	Hemagglutinins (Hemagglutinin)IBA 02/2020
1	Influenza Vaccines (Influenza Vaccine)FDA Link 02/2020
1	Broadly Neutralizing AntibodiesIBA 02/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Reactive Nitrogen SpeciesIBA 01/2020
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2020
1	posaconazole FDA Link 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Untranslated RNA (Noncoding RNA)IBA 01/2019
1	eltrombopag FDA Link 01/2018
1	romiplostim FDA Link 01/2018
1	Thrombopoietin ReceptorsIBA 01/2018
1	Inosine Triphosphate (ITP)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 08/2017
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017
1	X-linked zinc finger proteinIBA 12/2016
1	Decitabine FDA Link 12/2016
1	CurcuminIBA 07/2016
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2016
1	SmokeIBA 04/2016
1	AnticoagulantsIBA 01/2016
1	pullulanIBA 11/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2015

Therapy/Procedure

3	Transplantation 01/2020 - 02/2016
1	Erythrocyte Transfusion 12/2021
1	Length of Stay 02/2021
1	Neck Dissection (Radical Neck Dissection) 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 01/2016